Abhydrolase domain containing 2, an androgen target gene, promotes prostate cancer cell proliferation and migration

ABHD2 is a novel androgen-regulated gene that can promote prostate cancer growth and resistance to chemotherapy, and is a novel target for diagnosis and treatment of prostate cancer.